Post your job infront of 100,000+ qualified LP's and GP's.
Recently Filled Jobs
Firms you might be interested in
Biohaven Achieves Targeted Therapeutic Exposures Of Bhv-3500, A Third-generation Small Molecule Cgrp Receptor Antagonist
Posted on: Feb. 4, 2019, 8:31 a.m.
NEW HAVEN, Conn., Feb. 4, 2019 /PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN), a biotechnology company focused on advancing innovative therapies for neurological diseases, today announced that administration of intranasal BHV-3500 in a Phase 1 clinical trial has ... Full investment news articleRelevent to this post: State Administration of Foreign Exchange Bristol-Myers Squibb,